26 May 2026

strategyland.uk

Haleon PLC (HLN)

Rank #31 of 100 - Healthcare - UK Equities

Home/Stocks/Healthcare

Haleon PLC

HLN.L·Healthcare·Market Cap £30.1b

Rank #31 of 100

Data from Excel Model · 100 Stocks Analysed

£3.42

-8.96% YTD

Target: £4.24(+24.1%)

52W: £2.74 - £4.20

Score Analysis

Haleon PLC is ranked #31 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

43/100

Average Score

Liquidity

Weak72/100

Valuation

Weak89/100

Profitability

Excellent15/100

Solvency

Excellent18/100

Asset Efficiency

Excellent25/100

Mkt Trading

Good33/100

Technical

Fair47/100

1. Valuation

Score: 89/100

Is HLN undervalued compared to its peers and fair value metrics?

0/5

valuation criteria met

✗

FY26e P/E Ratio

16.4xRank 65/100

✗

FY27e P/E Ratio

14.9xRank 67/100

✗

Price-to-Book

2.03xRank 42/100

✗

Price-to-Tangible Book

N/ARank 101/100

✗

EV/EBITDA

14.2xRank 73/100

Key Valuation Metrics

Current P/E

18.5x

Price-to-Earnings

FY26e P/E

16.4x

Forward estimate

FY27e P/E

14.9x

Forward estimate

P/B Ratio

2.03x

Price-to-Book

P/TBV

N/A

Price-to-Tangible Book

EV/EBITDA

14.2x

Enterprise Value

FY26e EV/EBITDA

12.2x

Forward estimate

FY27e EV/EBITDA

12.2x

Forward estimate

Analyst Consensus Target

Current Price

£3.42

Consensus Target

£4.24

Potential

+24.1%

Target

Bloomberg Median Target: £4.22

2. Profitability

Score: 15/100

How profitable is HLN relative to its peers?

1/6

profitability criteria met

✗

TTM Profit Margin

15.2%Rank 59/100

–

Current ROE

10.2%

–

Current ROA

N/A

✓

FY26e EPS

0.23Rank 9/100

–

TTM EPS

0.21

–

Net Income Growth

N/A

Profit Margin

15.2%

ROE

10.2%

FY27e ROE

11.2%

ROA

N/A

Earnings Per Share

3. Financial Health

Score: 18/100

How strong is HLN's balance sheet and financial position?

1/4

solvency criteria met

–

Debt-to-Equity

52.2%

–

Interest Coverage

N/A

✓

Debt/EBITDA

Rank 23Rank 23/100

–

Altman Z-Score

2.49

Key Health Metrics

Quick Ratio

0.71

Below 1.0

Cash Ratio

0.92

Debt/Equity

52%

FCF Margin

0.2%

Altman Z-Score

2.49

Grey Zone

01.812.995+

4. Asset Efficiency

Score: 25/100

How efficiently does HLN deploy its assets and intellectual capital?

1/2

asset efficiency criteria met

–

Intangible/Asset

Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations

N/A

✓

R&D/Sales

Research & development spend relative to revenue — balanced R&D investment signals sustainable growth

Rank 10/100

Overall Asset Efficiency Rank

Rank within sector peers#25/100

Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.